Compare HBIO & GPMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HBIO | GPMT |
|---|---|---|
| Founded | 1901 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5M | 24.5M |
| IPO Year | 2000 | 2017 |
| Metric | HBIO | GPMT |
|---|---|---|
| Price | $9.50 | $2.47 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $11.50 | $9.38 |
| AVG Volume (30 Days) | 26.4K | ★ 42.1K |
| Earning Date | 11-10-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 15.04% |
| EPS Growth | N/A | ★ 73.58 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $116,176,000.00 | N/A |
| Revenue This Year | $4.09 | $166.29 |
| Revenue Next Year | $5.22 | $18.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.40 | $0.74 |
| 52 Week High | $10.20 | $7.61 |
| Indicator | HBIO | GPMT |
|---|---|---|
| Relative Strength Index (RSI) | 66.51 | 31.93 |
| Support Level | $8.01 | $1.39 |
| Resistance Level | N/A | $7.61 |
| Average True Range (ATR) | 0.51 | 0.35 |
| MACD | 0.09 | -0.33 |
| Stochastic Oscillator | 66.51 | 0.39 |
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.